The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.
(Q50760156)
scientific article published in July 1995
scientific article published in July 1995
Language:
Current Data About
The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.
other details
description | scientific article published in July 1995 |
External Links
(P356) |
10.1046/J.1471-4159.1995.65010218.X
|
(P698) |
7790863
|